Phase 3 Necrosis Clinical Trials
5 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–5 of 5 trials
Recruiting
Phase 3
Bevacizumab Versus Corticosteroids as First-line Treatment in Patients With Symptomatic Cerebral Radiation Necrosis After Radiation for High-grade Glioma or Brain Metastases
Radiation ToxicityBrain MetastasasesHigh Grade Glioma (III or IV)+4 more
The Netherlands Cancer Institute408 enrolled5 locationsNCT06888817
Recruiting
Phase 3
Combination Therapy: Hyperbaric Oxygen and PENTOCLO for Treatment of Osteoradionecrosis of the Mandible
OsteoradionecrosisOsteoradionecrosis of JawOsteoradionecrosis of the Mandible
Sunnybrook Health Sciences Centre24 enrolled1 locationNCT06055257
Recruiting
Phase 3
Corticodependent or Corticoresistant Brain Radionecrosis After Radiotherapy for Brain Metastases
Brain MetastasesRadionecrosis of Brain
Institut Cancerologie de l'Ouest84 enrolled10 locationsNCT06471465
Not Yet Recruiting
Phase 3
Comparison of zinc oxide eugenol and metapex as root canal filling material following pulpectomy in primary molars
Pulpal necrosis
Sana Ashfaq60 enrolled1 locationACTRN12623000785606
Completed
Phase 3
Does teriparatide reverse osteonecrosis of the jaw?
Osteonecrosis of the jaw
Western Campus, Melbourne Medical School, University of Melbourne68 enrolled1 locationACTRN12612000950864